PDB Short entry for 2HAI HEADER TRANSFERASE 12-JUN-06 2HAI TITLE CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE IN COMPLEX WITH NOVEL TITLE 2 CLASS OF DIHYDROPYRONE-CONTAINING INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATITIS C VIRUS NS5B RNA POLYMERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 2419-2988; COMPND 5 EC: 2.7.7.48; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_TAXID: 11103; SOURCE 4 STRAIN: GENOTYPE 1B; SOURCE 5 GENE: NS5B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PSW504V KEYWDS HCV RNA POLYMERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,R.L.LOVE REVDAT 4 03-APR-24 2HAI 1 REMARK REVDAT 3 20-OCT-21 2HAI 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 2HAI 1 VERSN REVDAT 1 05-SEP-06 2HAI 0 JRNL AUTH H.LI,J.TATLOCK,A.LINTON,J.GONZALEZ,A.BORCHARDT,P.DRAGOVICH, JRNL AUTH 2 T.JEWELL,T.PRINS,R.ZHOU,J.BLAZEL,H.PARGE,R.LOVE,M.HICKEY, JRNL AUTH 3 C.DOAN,S.SHI,R.DUGGAL,C.LEWIS,S.FUHRMAN JRNL TITL IDENTIFICATION AND STRUCTURE-BASED OPTIMIZATION OF NOVEL JRNL TITL 2 DIHYDROPYRONES AS POTENT HCV RNA POLYMERASE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 16 4834 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16824756 JRNL DOI 10.1016/J.BMCL.2006.06.065 REMARK 2 REMARK 2 RESOLUTION. 1.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 83251 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1700 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.58 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.62 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5754 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.40 REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.3830 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4304 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 596 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.26000 REMARK 3 B22 (A**2) : -0.26000 REMARK 3 B33 (A**2) : 0.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.096 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.092 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.070 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.984 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4432 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6034 ; 1.044 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 563 ; 4.930 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 177 ;32.206 ;22.994 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 710 ;11.827 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 33 ;15.353 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 686 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3335 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2197 ; 0.186 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3136 ; 0.296 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 498 ; 0.097 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.186 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 22 ; 0.208 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2880 ; 0.551 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4518 ; 0.931 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1781 ; 1.434 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1515 ; 2.247 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HAI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038133. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAR-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 83251 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.580 REMARK 200 RESOLUTION RANGE LOW (A) : 22.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 27.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.72000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: HCV NS5B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% MEPEG 2000, 0.2M AMMONIUM SULFATE, REMARK 280 0.1M AMMONIUM ACETATE, PH 5.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 89.91500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 41.62750 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 41.62750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 44.95750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 41.62750 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 41.62750 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 134.87250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 41.62750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.62750 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 44.95750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 41.62750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.62750 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 134.87250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 89.91500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 680 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 563 REMARK 465 LEU A 564 REMARK 465 SER A 565 REMARK 465 ARG A 566 REMARK 465 ALA A 567 REMARK 465 ARG A 568 REMARK 465 PRO A 569 REMARK 465 ARG A 570 REMARK 465 HIS A 571 REMARK 465 HIS A 572 REMARK 465 HIS A 573 REMARK 465 HIS A 574 REMARK 465 HIS A 575 REMARK 465 HIS A 576 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 43 CD NE CZ NH1 NH2 REMARK 470 LYS A 74 CD CE NZ REMARK 470 LYS A 79 CD CE NZ REMARK 470 LYS A 81 CG CD CE NZ REMARK 470 LYS A 90 CG CD CE NZ REMARK 470 LYS A 98 CE NZ REMARK 470 LYS A 100 CD CE NZ REMARK 470 LYS A 106 CD CE NZ REMARK 470 ARG A 114 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 124 CG CD CE NZ REMARK 470 LYS A 141 NZ REMARK 470 LYS A 155 NZ REMARK 470 ARG A 222 NE CZ NH1 NH2 REMARK 470 GLN A 355 CG CD OE1 NE2 REMARK 470 LYS A 379 CG CD CE NZ REMARK 470 HIS A 402 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 531 CE NZ REMARK 470 LYS A 535 CG CD CE NZ REMARK 470 GLN A 544 CB CG CD OE1 NE2 REMARK 470 ASP A 546 CB CG OD1 OD2 REMARK 470 SER A 548 CB OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 131 -43.41 -132.67 REMARK 500 LEU A 260 -56.97 -124.76 REMARK 500 ILE A 424 -61.13 -104.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PFI A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OS5 RELATED DB: PDB REMARK 900 HCV NS5B COMPLEXED WITH NOVEL NON-COMPETITIVE INHIBITOR DBREF 2HAI A 1 570 UNP P26663 POLG_HCVBK 2419 2988 SEQADV 2HAI GLN A 47 UNP P26663 LEU 2465 ENGINEERED MUTATION SEQADV 2HAI TYR A 101 UNP P26663 PHE 2519 ENGINEERED MUTATION SEQADV 2HAI ARG A 114 UNP P26663 LYS 2532 ENGINEERED MUTATION SEQADV 2HAI CSD A 223 UNP P26663 CYS 2641 MODIFIED RESIDUE SEQADV 2HAI CME A 366 UNP P26663 CYS 2784 MODIFIED RESIDUE SEQADV 2HAI GLN A 544 UNP P26663 ARG 2962 CONFLICT SEQADV 2HAI HIS A 571 UNP P26663 EXPRESSION TAG SEQADV 2HAI HIS A 572 UNP P26663 EXPRESSION TAG SEQADV 2HAI HIS A 573 UNP P26663 EXPRESSION TAG SEQADV 2HAI HIS A 574 UNP P26663 EXPRESSION TAG SEQADV 2HAI HIS A 575 UNP P26663 EXPRESSION TAG SEQADV 2HAI HIS A 576 UNP P26663 EXPRESSION TAG SEQRES 1 A 576 SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR PRO SEQRES 2 A 576 CYS ALA ALA GLU GLU SER LYS LEU PRO ILE ASN ALA LEU SEQRES 3 A 576 SER ASN SER LEU LEU ARG HIS HIS ASN MET VAL TYR ALA SEQRES 4 A 576 THR THR SER ARG SER ALA GLY GLN ARG GLN LYS LYS VAL SEQRES 5 A 576 THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR ARG SEQRES 6 A 576 ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR VAL SEQRES 7 A 576 LYS ALA LYS LEU LEU SER VAL GLU GLU ALA CYS LYS LEU SEQRES 8 A 576 THR PRO PRO HIS SER ALA LYS SER LYS TYR GLY TYR GLY SEQRES 9 A 576 ALA LYS ASP VAL ARG ASN LEU SER SER ARG ALA VAL ASN SEQRES 10 A 576 HIS ILE HIS SER VAL TRP LYS ASP LEU LEU GLU ASP THR SEQRES 11 A 576 VAL THR PRO ILE ASP THR THR ILE MET ALA LYS ASN GLU SEQRES 12 A 576 VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS PRO SEQRES 13 A 576 ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG VAL SEQRES 14 A 576 CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR LEU SEQRES 15 A 576 PRO GLN VAL VAL MET GLY SER SER TYR GLY PHE GLN TYR SEQRES 16 A 576 SER PRO GLY GLN ARG VAL GLU PHE LEU VAL ASN THR TRP SEQRES 17 A 576 LYS SER LYS LYS ASN PRO MET GLY PHE SER TYR ASP THR SEQRES 18 A 576 ARG CSD PHE ASP SER THR VAL THR GLU ASN ASP ILE ARG SEQRES 19 A 576 VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA PRO SEQRES 20 A 576 GLU ALA ARG GLN ALA ILE LYS SER LEU THR GLU ARG LEU SEQRES 21 A 576 TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN ASN SEQRES 22 A 576 CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU THR SEQRES 23 A 576 THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS ALA SEQRES 24 A 576 SER ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS THR SEQRES 25 A 576 MET LEU VAL ASN GLY ASP ASP LEU VAL VAL ILE CYS GLU SEQRES 26 A 576 SER ALA GLY THR GLN GLU ASP ALA ALA SER LEU ARG VAL SEQRES 27 A 576 PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO GLY SEQRES 28 A 576 ASP PRO PRO GLN PRO GLU TYR ASP LEU GLU LEU ILE THR SEQRES 29 A 576 SER CME SER SER ASN VAL SER VAL ALA HIS ASP ALA SER SEQRES 30 A 576 GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR THR SEQRES 31 A 576 PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS THR SEQRES 32 A 576 PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET TYR ALA SEQRES 33 A 576 PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS PHE SEQRES 34 A 576 PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS ALA SEQRES 35 A 576 LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE GLU SEQRES 36 A 576 PRO LEU ASP LEU PRO GLN ILE ILE GLU ARG LEU HIS GLY SEQRES 37 A 576 LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY GLU SEQRES 38 A 576 ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY VAL SEQRES 39 A 576 PRO PRO LEU ARG VAL TRP ARG HIS ARG ALA ARG SER VAL SEQRES 40 A 576 ARG ALA ARG LEU LEU SER GLN GLY GLY ARG ALA ALA THR SEQRES 41 A 576 CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL LYS THR LYS SEQRES 42 A 576 LEU LYS LEU THR PRO ILE PRO ALA ALA SER GLN LEU ASP SEQRES 43 A 576 LEU SER GLY TRP PHE VAL ALA GLY TYR SER GLY GLY ASP SEQRES 44 A 576 ILE TYR HIS SER LEU SER ARG ALA ARG PRO ARG HIS HIS SEQRES 45 A 576 HIS HIS HIS HIS MODRES 2HAI CSD A 223 CYS 3-SULFINOALANINE MODRES 2HAI CME A 366 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CSD A 223 8 HET CME A 366 10 HET PFI A 601 26 HETNAM CSD 3-SULFINOALANINE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM PFI (6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL) HETNAM 2 PFI ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 CSD C3 H7 N O4 S FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 PFI C21 H27 F O4 FORMUL 3 HOH *596(H2 O) HELIX 1 1 ASN A 24 SER A 29 1 6 HELIX 2 2 HIS A 33 ASN A 35 5 3 HELIX 3 3 THR A 41 ARG A 43 5 3 HELIX 4 4 SER A 44 THR A 53 1 10 HELIX 5 5 ASP A 61 SER A 76 1 16 HELIX 6 6 SER A 84 LEU A 91 1 8 HELIX 7 7 GLY A 104 ASN A 110 1 7 HELIX 8 8 SER A 112 ASP A 129 1 18 HELIX 9 9 ASP A 164 GLY A 188 1 25 HELIX 10 10 SER A 189 TYR A 195 5 7 HELIX 11 11 SER A 196 SER A 210 1 15 HELIX 12 12 CSD A 223 VAL A 228 1 6 HELIX 13 13 THR A 229 GLN A 241 1 13 HELIX 14 14 ALA A 246 LEU A 260 1 15 HELIX 15 15 THR A 286 ALA A 306 1 21 HELIX 16 16 GLY A 328 TYR A 346 1 19 HELIX 17 17 ASP A 359 ILE A 363 5 5 HELIX 18 18 PRO A 388 ARG A 401 1 14 HELIX 19 19 ASN A 406 TYR A 415 1 10 HELIX 20 20 THR A 418 ILE A 424 1 7 HELIX 21 21 ILE A 424 GLU A 437 1 14 HELIX 22 22 GLU A 455 LEU A 457 5 3 HELIX 23 23 ASP A 458 GLY A 468 1 11 HELIX 24 24 LEU A 469 SER A 473 5 5 HELIX 25 25 SER A 478 GLY A 493 1 16 HELIX 26 26 PRO A 496 GLY A 515 1 20 HELIX 27 27 GLY A 515 PHE A 526 1 12 HELIX 28 28 ASN A 527 VAL A 530 5 4 HELIX 29 29 ILE A 539 GLN A 544 1 6 SHEET 1 A 5 TYR A 4 TRP A 6 0 SHEET 2 A 5 ASN A 273 ARG A 277 -1 O TYR A 276 N THR A 5 SHEET 3 A 5 GLY A 264 THR A 267 -1 N LEU A 266 O CYS A 274 SHEET 4 A 5 THR A 136 ALA A 140 1 N THR A 136 O THR A 267 SHEET 5 A 5 LEU A 159 PHE A 162 -1 O PHE A 162 N THR A 137 SHEET 1 B 2 VAL A 37 ALA A 39 0 SHEET 2 B 2 VAL A 144 CYS A 146 -1 O PHE A 145 N TYR A 38 SHEET 1 C 3 PRO A 214 TYR A 219 0 SHEET 2 C 3 ASP A 319 GLU A 325 -1 O CYS A 324 N MET A 215 SHEET 3 C 3 GLN A 309 ASN A 316 -1 N GLN A 309 O GLU A 325 SHEET 1 D 2 ASN A 369 HIS A 374 0 SHEET 2 D 2 ARG A 380 THR A 385 -1 O VAL A 381 N ALA A 373 SHEET 1 E 2 LEU A 443 ILE A 447 0 SHEET 2 E 2 ALA A 450 ILE A 454 -1 O ILE A 454 N LEU A 443 SSBOND 1 CYS A 303 CYS A 311 1555 1555 2.04 LINK C ARG A 222 N CSD A 223 1555 1555 1.33 LINK C CSD A 223 N PHE A 224 1555 1555 1.33 LINK C SER A 365 N CME A 366 1555 1555 1.33 LINK C CME A 366 N SER A 367 1555 1555 1.34 SITE 1 AC1 12 LEU A 419 ARG A 422 MET A 423 HIS A 475 SITE 2 AC1 12 SER A 476 ILE A 482 ALA A 486 LEU A 497 SITE 3 AC1 12 ARG A 501 HOH A 641 HOH A 653 HOH A1091 CRYST1 83.255 83.255 179.830 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012011 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012011 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005561 0.00000